Evidence for spontaneous immunosuppression in autoimmune hepatitis

Area of Science:

• Immunology
• Hepatology
• Autoimmune Diseases

Background:

• Autoimmune hepatitis (AIH) exhibits variable clinical courses, including spontaneous remissions, suggesting immune system regulation.
• Experimental autoimmune hepatitis (EAH) shows spontaneous recovery linked to immune suppression, prompting investigation in human AIH.

Purpose of the Study:

• To investigate immunoregulatory phenomena in patients with autoimmune hepatitis (AIH).
• To examine T-cell reactivity to liver antigens and explore suppressive mechanisms in AIH.

Main Methods:

• Assessed T-cell reactivity to soluble human liver antigens in 11 active AIH patients and 30 controls with other liver diseases.
• Compared T-cell responses in AIH patients during active disease, post-immunosuppression, and remission.
• Evaluated in vivo immune responsiveness using tetanus toxoid booster immunization in AIH patients and controls.

Main Results:

• T-cell reactivity to liver antigens was primarily observed in AIH patients and significantly reduced in remission.
• Peripheral blood cells from AIH remission phases suppressed liver-specific T-cell responses from active disease phases.
• AIH patients showed impaired in vivo immune responsiveness to tetanus toxoid compared to controls.

Conclusions:

• Patients with autoimmune hepatitis exhibit suppressed T-cell responses, particularly in remission, suggesting an active immunoregulatory mechanism.
• The findings indicate that immune cells from AIH remission can suppress disease-specific T-cell reactivity.
• Impaired systemic immune responsiveness in AIH patients points to broader immune dysregulation.